Abadan, Xia Claire P.

HRN: 20-93-70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2024
CEFUROXIME 750MG (VIAL)
01/24/2024
01/30/2024
IV
300
Q8
Uti
Waiting Final Action 
01/25/2024
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
01/25/2024
01/28/2024
PO
5ml
BID
Ascariasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: